Warning: The NCBI web site requires JavaScript to function. more...
Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
Niméus-Malmström E, Krogh M, Malmström P, Strand C, Fredriksson I, Karlsson P, Nordenskjöld B, Stål O, Ostberg G, Peterson C, Fernö M.
Breast Cancer Res. 2008;10(2):R34. Epub 2008 Apr 22.
Related citations
[Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
Fodor J.
Magy Onkol. 2009 Mar;53(1):7-14. Hungarian.
Gene expression profiles of primary breast carcinomas from patients at high risk for local recurrence after breast-conserving therapy.
Kreike B, Halfwerk H, Kristel P, Glas A, Peterse H, Bartelink H, van de Vijver MJ.
Clin Cancer Res. 2006 Oct 1;12(19):5705-12.
Expression of p53, glutathione S-transferase-pi, and Bcl-2 proteins and benefit from adjuvant radiotherapy in breast cancer.
Silvestrini R, Veneroni S, Benini E, Daidone MG, Luisi A, Leutner M, Maucione A, Kenda R, Zucali R, Veronesi U.
J Natl Cancer Inst. 1997 May 7;89(9):639-45.
Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
Nuyten DS, Kreike B, Hart AA, Chi JT, Sneddon JB, Wessels LF, Peterse HJ, Bartelink H, Brown PO, Chang HY, van de Vijver MJ.
Breast Cancer Res. 2006;8(5):R62.
Oestrogen receptor status predicts local recurrence following breast conservation surgery for early breast cancer.
Yaghan R, Stanton PD, Robertson KW, Going JJ, Murray GD, McArdle CS.
Eur J Surg Oncol. 1998 Oct;24(5):424-6.
Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):357-64.
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation.
Haffty BG, Yang Q, Moran MS, Tan AR, Reiss M.
Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):1006-13. Epub 2008 Feb 11.
Molecular predictive factors for local recurrence and distant metastasis of breast cancer after lumpectomy with postoperative radiation therapy.
Amornmarn R, Bui MM, Prempree TB, Masood S.
Ann Clin Lab Sci. 2000 Jan;30(1):33-40.
Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y, Qian Y, Wei L, Abraham J, Shi X, Castranova V, Harner EJ, Flynn DC, Guo L.
Clin Cancer Res. 2007 Apr 1;13(7):2014-22.
When not to give radiation therapy after breast conservation surgery for breast cancer.
de Csepel J, Tartter PI, Gajdos C.
J Surg Oncol. 2000 Aug;74(4):273-7.
[Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
Magy Onkol. 2007;51(2):127-31. Epub 2007 Jul 29. Hungarian.
Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?
Yildirim E, Berberoglu U.
Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1024-9. Epub 2007 Mar 29.
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy.
Yang Q, Moran MS, Haffty BG.
Breast Cancer Res Treat. 2009 May;115(2):343-8. Epub 2008 May 31.
[Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C, Orosz Z, Kahán Z, Gábor G, Jani N, Cserni G, Hadijev J, Kulka J, Sulyok Z, Boross G, Lázár G, László Z, Diczházi C, Udvarhelyi N, Szabó E, Péntek Z, Major T, Fodor J.
Magy Onkol. 2008 Sep;52(3):269-77. Hungarian.
Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy.
Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR.
J Clin Oncol. 2008 May 10;26(14):2373-8. Epub 2008 Apr 14. Erratum in: J Clin Oncol. 2008 Jun;26(18):3110.
Breast conservation surgery achieving>or=2 mm tumor-free margins results in decreased local-regional recurrence rates.
Kunos C, Latson L, Overmoyer B, Silverman P, Shenk R, Kinsella T, Lyons J.
Breast J. 2006 Jan-Feb;12(1):28-36.
Recurrence in breast cancer. Analysis with frailty model.
Gohari MR, Mahmoudi M, Mohammed K, Pasha E, Khodabakhshi R.
Saudi Med J. 2006 Aug;27(8):1187-93.
Local recurrence after mastectomy for breast cancer: analysis of clinicopathological, biological and prognostic characteristics.
Carreño G, Del Casar JM, Corte MD, González LO, Bongera M, Merino AM, Juan G, Obregón R, Martínez E, Vizoso FJ.
Breast Cancer Res Treat. 2007 Mar;102(1):61-73. Epub 2006 Jul 19.
Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
Vordermark D, Lackenbauer A, Wulf J, Guckenberger M, Flentje M.
Oncol Rep. 2007 Nov;18(5):1335-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on